
NEWS MAKER @NEWS_MAKER
Merck Senior Vice President of Global Medical Affairs, Eliav Barr, told the Financial Times that Pfizer's COVID-19 pill would be unsuitable for some patients because of the ANTI-HIV DRUG, ritonavir, that's included in the regimen for Pfizer's oral COVID therapy Paxlovid. — PolitiTweet.org